| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/16/2007 | US7282476 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 10/16/2007 | US7282364 Expression cassette generated from these sequences; generating an immune response in a subject |
| 10/16/2007 | US7282353 Protein isolation |
| 10/16/2007 | US7282351 Prostatic growth factor |
| 10/16/2007 | US7282343 Administering psoralen ultraviolet A (PUVA) in combination with fluoroquinolone, a macrolide, tetracycline, a tetracycline derivative, penicillin, or penicillin derivative; mycosis fungoides, Sezary syndrome, lymphomatoid papillosis, Ki-1 lymphoma, exfoliative exematous rash, and digitate parapsoriasis |
| 10/16/2007 | US7282341 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time |
| 10/16/2007 | US7282210 Process for the in vitro culture of different stages of tissular parasites |
| 10/16/2007 | US7282209 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders |
| 10/16/2007 | US7282207 Multimeric polypeptide antigen; uterine cancer |
| 10/16/2007 | US7282206 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 10/16/2007 | US7282205 Anti-hepatitis A virus antibodies |
| 10/16/2007 | US7282204 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA |
| 10/16/2007 | US7282203 Use of NOTCH pathway interfering agents for treatment of plasma cell disorders |
| 10/16/2007 | US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders |
| 10/16/2007 | US7282198 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
| 10/16/2007 | CA2326413C Process for enriching for helicobacter pylori neutrophil activating protein (nap) |
| 10/16/2007 | CA2157375C Extraction of cell-bound protein from bordetella |
| 10/16/2007 | CA2124126C Monoclonal antibodies and fv specific for cd2 antigen |
| 10/14/2007 | CA2584894A1 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus |
| 10/11/2007 | WO2007115143A2 Dead spindle pto with compliant grounding mechanism |
| 10/11/2007 | WO2007115135A2 Aircraft passenger seat |
| 10/11/2007 | WO2007115066A2 Facilitating application synchronization with a reservation protocol at a sender without application receiver participation |
| 10/11/2007 | WO2007115056A2 Wireless repeater with universal server base and modular donor antenna options |
| 10/11/2007 | WO2007114878A2 Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli |
| 10/11/2007 | WO2007114851A1 Methods and compositions to induce cell death of invasive tumors |
| 10/11/2007 | WO2007114680A1 Anti-inflammatory protein ophthalmic preparation |
| 10/11/2007 | WO2007114496A1 Novel anti-cd98 antibody |
| 10/11/2007 | WO2007114340A1 Pseudomonas aeruginosa outer membrane protein pa0427 |
| 10/11/2007 | WO2007114325A1 Antibody modification method for purifying bispecific antibody |
| 10/11/2007 | WO2007114319A1 Method for control of blood kinetics of antibody |
| 10/11/2007 | WO2007114239A1 ANTI-CANCER AGENT COMPRISING DGKα INHIBITOR |
| 10/11/2007 | WO2007113819A2 Methods and compositions for preventing and treating streptococcus pneumoniae infection |
| 10/11/2007 | WO2007113665A2 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
| 10/11/2007 | WO2007113648A2 Ctla4 antibody combination therapy |
| 10/11/2007 | WO2007113633A2 Immunogenic compositions comprising cat allergen fel dl |
| 10/11/2007 | WO2007113598A2 Peptide mimetope vaccine of- and antibodies against 6b pneumococcal polysaccharides |
| 10/11/2007 | WO2007113301A1 Pharmaceuticals for influencing the reaction of the human immune system |
| 10/11/2007 | WO2007113224A2 Conjugation process for pnag and a carrier protein |
| 10/11/2007 | WO2007113223A2 Immunogenic composition |
| 10/11/2007 | WO2007113172A2 Antibodies against amyloid-beta peptide |
| 10/11/2007 | WO2007112750A2 Tablets and capsules comprising immunogens for oral administration |
| 10/11/2007 | WO2007112747A1 Immunogen combinations |
| 10/11/2007 | WO2007112567A1 Synthetic archaeal glycolipid adjuvants |
| 10/11/2007 | WO2007112518A1 Live attenuated salmonella vaccine |
| 10/11/2007 | WO2007112475A1 A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 10/11/2007 | WO2007106956A1 Live attenuated salmonella vaccine |
| 10/11/2007 | WO2007087851A8 Method for producing epitomers and their uses on carrier microorganisms |
| 10/11/2007 | WO2007085567A3 Synergistic compositions for treating hiv |
| 10/11/2007 | WO2007085459A3 Method for the in vitro diagnosis of chlamydophila pneumoniae infections |
| 10/11/2007 | WO2007062851A3 Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences |
| 10/11/2007 | WO2007030642A3 Toxin conjugated eph receptor antibodies |
| 10/11/2007 | WO2007024368A3 Compositions and methods to control angiogenesis with cupredoxins |
| 10/11/2007 | WO2006124451A3 Anti-il-13 antibodies, compositions, methods and uses |
| 10/11/2007 | WO2006121871A3 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 10/11/2007 | WO2006109071A8 Vaccine against burkholderia infections |
| 10/11/2007 | WO2006071934A9 Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs |
| 10/11/2007 | US20070238869 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis |
| 10/11/2007 | US20070238684 For an improved in vitro and in vivo transformation of particular cells, for example for somatic gene therapy; diagnosis, increased infectivity for cells of low susceptibility, such as haematopoietic cells |
| 10/11/2007 | US20070238655 Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis |
| 10/11/2007 | US20070238651 Nucleic acids and proteins of a rat ganglioside GM1-specific alpha1-2fucosyltransferase and uses thereof |
| 10/11/2007 | US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4 |
| 10/11/2007 | US20070238195 Conformational and topological protein regulation |
| 10/11/2007 | US20070238182 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 10/11/2007 | US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
| 10/11/2007 | US20070237831 Nanoparticles for monoclonal antibody delivery |
| 10/11/2007 | US20070237826 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
| 10/11/2007 | US20070237795 Cryopreservation of Haptenized Tumor Cells |
| 10/11/2007 | US20070237794 Compounds and Methods for Diagnosis and Treatment of Leishmaniasis |
| 10/11/2007 | US20070237793 Attenuated or mutated pasteurella for use as tool in developing bactericidal agents; immunotherapy; immunogens for vaccines |
| 10/11/2007 | US20070237792 Determining a correlation between the bioactive agent and a marker compound in the formulation by deriving a ratio of the bioactive agent to the marker such as albumin, and human serum albumin |
| 10/11/2007 | US20070237791 Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (cfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E.coli |
| 10/11/2007 | US20070237790 Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes |
| 10/11/2007 | US20070237789 DNA-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 10/11/2007 | US20070237788 Non-live trivalent influenza vaccine for one-dose intradermal delivery |
| 10/11/2007 | US20070237787 Methods for use of tslp and agonists and antagonists thereof |
| 10/11/2007 | US20070237785 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 10/11/2007 | US20070237784 IdeS, an IgG-degrading enzyme of Streptococcus pyogenes |
| 10/11/2007 | US20070237783 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 10/11/2007 | US20070237782 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| 10/11/2007 | US20070237781 Biologically active metal-containing nucleic acids |
| 10/11/2007 | US20070237780 Method of preventing or reducing the risk or incidence of cancer |
| 10/11/2007 | US20070237779 Binding constructs and methods for use thereof |
| 10/11/2007 | US20070237778 Using bone morphogenic protein specific immunoglobulin for treatment and prevention of osteopenia, osteomalacia, osteoporosis, osteomyeloma, osteodystrophy and paget's disease |
| 10/11/2007 | US20070237777 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
| 10/11/2007 | US20070237776 Binds to hIL-18R alpha with high affinity and by the ability to neutralize hIL-18 activity, including IL-18-induced interferon gamma expression and IL-18-induced cellular activation; sepsis; cardiovascular disorders; liver injury; arthritis, including rheumatoid arthritis; inflammatory bowel diseases |
| 10/11/2007 | US20070237775 Anti-Ghrelin Antibodies |
| 10/11/2007 | US20070237774 Method for using BOC/CDO to Modulate Hedgehog Signaling |
| 10/11/2007 | US20070237773 Human sema4a protein antibodies and uses thereof |
| 10/11/2007 | US20070237772 Tumor association of mdl-1 and methods |
| 10/11/2007 | US20070237771 Multicomponent conjugates which bind to target molecules and stimulate T cell lysis |
| 10/11/2007 | US20070237770 Novel compositions and methods in cancer |
| 10/11/2007 | US20070237769 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 10/11/2007 | US20070237768 Fibroblast growth factor 21 compounds fused to proteins that have the effect of extending the in vivo half-life of the polypeptides; these fusion proteins can be used to treat non-insulin dependent diabetes mellitus, obesity and metabolic syndrome |
| 10/11/2007 | US20070237767 Fc Variants Having Decreased Affinity for FcyRllla |
| 10/11/2007 | US20070237766 Fc Variants Having Increased Affinity for FcyRllla |
| 10/11/2007 | US20070237765 Fc Variants Having Increased Affinity for FcyRl |
| 10/11/2007 | US20070237764 Binding polypeptides with restricted diversity sequences |
| 10/11/2007 | US20070237763 Compositions and methods for the treatment of cancer |
| 10/11/2007 | US20070237762 Process for Concentration of Antibodies and Therapeutic Products Thereof |
| 10/11/2007 | US20070237761 Chimeric Anti Cd44 Antibodies and Their Use for Treating Acute Myeloid Leukemia |